ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...
Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...
Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
Please provide your email address to receive an email when new articles are posted on . A limited understanding of non-European DNA may hinder genetic testing interpretations, leading to disparities ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...
India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy, the ...
8don MSN
AIIMS introduces free drug level testing for epilepsy patients, ends costly outside referrals
In major relief for epilepsy patients, AIIMS New Delhi began providing free Therapeutic Drug Monitoring (TDM) from January 1 ...
QUAD CITIES – The Epilepsy Foundation will be hosting an informative evening, "Genetic Testing for Epilespy" on Thursday, June 5th at UnityPoint Health-Trinity, 500 John Deere Rd., Moline, IL starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback